No Prescription |
 |
 | ||
|
SSDee Cream Silvadene |
|
| ||
No Prescription » Prescription Drugs 15 » SSDee Cream Silvadene Silver sulfadiazine a sulfa drug is used to prevent and treat infections of second- and third-degree burns. It kills a wide variety of bacteria.How should this medicine be used? Silver sulfadiazine comes in a cream. Silver sulfadiazine usually is applied once or twice a day. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Use silver sulfadiazine exactly as directed. Do not use more or less of it or use it more often than prescribed by your doctor.Do not apply this drug to infants less than 2 months of age.Do not stop using silver sulfadiazine until your doctor tells you to do so. Your burn must be healed so that infection is no longer a problem. Gently wash the burned skin area daily to help remove dead skin. If your burn becomes infected or if your infection worsens call your doctor.Before applying the medication clean the burned area and remove any dead or burned skin. Always wear a sterile disposable glove when you apply silver sulfadiazine. Cover the cleaned burned area with a 1/16-inch (0.2-centimeter) thickness of cream. Keep the burned area covered with cream at all times; reapply the cream to any area that becomes uncovered. Buy SSDee Cream Silvadene and other Prescription Drugs 15 products online at Medstore. Buy Online at Medstore - Click Here!
About SSDee Cream Silvadene: Product Type: Prescription Drugs 15 SSDee Cream (Silvadene Generic Silver Sulphadiazene ) SSDee Cream (Silvadene Generic Silver Sulphadiazene) Silvadene Generic Silver Sulphadiazene 1%w/v Silvadene Generic Silver Sulphadiazene SSDee Cream
View more Prescription Drugs 15 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
